1	Idarucizumab	idarucizumab	NCMS000	-	-	0-12	587(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
2	.	.	Fp	-	-	12-13	587(1)_ANS_clinical_caseMIR	SENT1	-	-

